Does Sildenafil Increase Exercise Performance in Air Pollution?
NCT ID: NCT00808912
Last Updated: 2010-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2008-12-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
NCT00517933
Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness
NCT00627965
The Impact of Sildenafil on the Pulmonary Circulation in Healthy Trained and Untrained Humans
NCT04985929
Endurance Performance at Altitude
NCT03710369
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
NCT00359736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Subjects will exercise in a high air pollutant environment after ingesting a standard dose of sildenafil.
sildenafil
sildenafil 50 mg ingested orally 1 hour prior to exercise testing
2
Subjects will exercise in a low pollutant environment after ingesting a standard dose of sildenafil.
sildenafil
sildenafil 50 mg ingested orally 1 hour prior to exercise testing
3
Subjects will exercise in a high pollutant environment after ingesting a placebo.
placebo
matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.
4
Subjects will exercise in a low pollutant environment after ingesting a placebo.
placebo
matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sildenafil
sildenafil 50 mg ingested orally 1 hour prior to exercise testing
placebo
matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* asthmatic
* active participants in endurance sports.
Exclusion Criteria
* history of heart disease
* pulmonary arterial hypertension
* pulmonary emboli
* diagnosis of moderate to severe asthma (FEV1 \<75% predicted)
* pregnant or lactating
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marywood University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marywood University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth W Rundell, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Marywood University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marywood University
Scranton, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MU2007-028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.